These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

771 related items for PubMed ID: 30395637

  • 1. HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
    LaBranche CC, McGuire AT, Gray MD, Behrens S, Kwong PDK, Chen X, Zhou T, Sattentau QJ, Peacock J, Eaton A, Greene K, Gao H, Tang H, Perez LG, Chen X, Saunders KO, Kwong PD, Mascola JR, Haynes BF, Stamatatos L, Montefiori DC.
    PLoS Pathog; 2018 Nov; 14(11):e1007431. PubMed ID: 30395637
    [Abstract] [Full Text] [Related]

  • 2. Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier.
    Bonsignori M, Scott E, Wiehe K, Easterhoff D, Alam SM, Hwang KK, Cooper M, Xia SM, Zhang R, Montefiori DC, Henderson R, Nie X, Kelsoe G, Moody MA, Chen X, Joyce MG, Kwong PD, Connors M, Mascola JR, McGuire AT, Stamatatos L, Medina-Ramírez M, Sanders RW, Saunders KO, Kepler TB, Haynes BF.
    Immunity; 2018 Dec 18; 49(6):1162-1174.e8. PubMed ID: 30552024
    [Abstract] [Full Text] [Related]

  • 3. Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.
    Duan H, Chen X, Boyington JC, Cheng C, Zhang Y, Jafari AJ, Stephens T, Tsybovsky Y, Kalyuzhniy O, Zhao P, Menis S, Nason MC, Normandin E, Mukhamedova M, DeKosky BJ, Wells L, Schief WR, Tian M, Alt FW, Kwong PD, Mascola JR.
    Immunity; 2018 Aug 21; 49(2):301-311.e5. PubMed ID: 30076101
    [Abstract] [Full Text] [Related]

  • 4. Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site.
    Gristick HB, von Boehmer L, West AP, Schamber M, Gazumyan A, Golijanin J, Seaman MS, Fätkenheuer G, Klein F, Nussenzweig MC, Bjorkman PJ.
    Nat Struct Mol Biol; 2016 Oct 21; 23(10):906-915. PubMed ID: 27617431
    [Abstract] [Full Text] [Related]

  • 5. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.
    Liang Y, Guttman M, Williams JA, Verkerke H, Alvarado D, Hu SL, Lee KK.
    J Virol; 2016 Oct 15; 90(20):9224-36. PubMed ID: 27489265
    [Abstract] [Full Text] [Related]

  • 6. Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation.
    Crooks ET, Grimley SL, Cully M, Osawa K, Dekkers G, Saunders K, Rämisch S, Menis S, Schief WR, Doria-Rose N, Haynes B, Murrell B, Cale EM, Pegu A, Mascola JR, Vidarsson G, Binley JM.
    PLoS Pathog; 2018 May 15; 14(5):e1007024. PubMed ID: 29718999
    [Abstract] [Full Text] [Related]

  • 7. Targeted N-glycan deletion at the receptor-binding site retains HIV Env NFL trimer integrity and accelerates the elicited antibody response.
    Dubrovskaya V, Guenaga J, de Val N, Wilson R, Feng Y, Movsesyan A, Karlsson Hedestam GB, Ward AB, Wyatt RT.
    PLoS Pathog; 2017 Sep 15; 13(9):e1006614. PubMed ID: 28902916
    [Abstract] [Full Text] [Related]

  • 8. Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability.
    Dubrovskaya V, Tran K, Ozorowski G, Guenaga J, Wilson R, Bale S, Cottrell CA, Turner HL, Seabright G, O'Dell S, Torres JL, Yang L, Feng Y, Leaman DP, Vázquez Bernat N, Liban T, Louder M, McKee K, Bailer RT, Movsesyan A, Doria-Rose NA, Pancera M, Karlsson Hedestam GB, Zwick MB, Crispin M, Mascola JR, Ward AB, Wyatt RT.
    Immunity; 2019 Nov 19; 51(5):915-929.e7. PubMed ID: 31732167
    [Abstract] [Full Text] [Related]

  • 9. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
    McGuire AT, Glenn JA, Lippy A, Stamatatos L.
    J Virol; 2014 Mar 19; 88(5):2645-57. PubMed ID: 24352455
    [Abstract] [Full Text] [Related]

  • 10. Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization.
    Parks KR, MacCamy AJ, Trichka J, Gray M, Weidle C, Borst AJ, Khechaduri A, Takushi B, Agrawal P, Guenaga J, Wyatt RT, Coler R, Seaman M, LaBranche C, Montefiori DC, Veesler D, Pancera M, McGuire A, Stamatatos L.
    Cell Rep; 2019 Dec 03; 29(10):3060-3072.e7. PubMed ID: 31801073
    [Abstract] [Full Text] [Related]

  • 11. A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope.
    Joshi VR, Claiborne DT, Pack ML, Power KA, Newman RM, Batorsky R, Bean DJ, Goroff MS, Lingwood D, Seaman MS, Rosenberg E, Allen TM.
    J Virol; 2024 Mar 19; 98(3):e0172023. PubMed ID: 38412036
    [Abstract] [Full Text] [Related]

  • 12. Structural basis for germline antibody recognition of HIV-1 immunogens.
    Scharf L, West AP, Sievers SA, Chen C, Jiang S, Gao H, Gray MD, McGuire AT, Scheid JF, Nussenzweig MC, Stamatatos L, Bjorkman PJ.
    Elife; 2016 Mar 21; 5():. PubMed ID: 26997349
    [Abstract] [Full Text] [Related]

  • 13. Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor.
    Kong L, Ju B, Chen Y, He L, Ren L, Liu J, Hong K, Su B, Wang Z, Ozorowski G, Ji X, Hua Y, Chen Y, Deller MC, Hao Y, Feng Y, Garces F, Wilson R, Dai K, O'Dell S, McKee K, Mascola JR, Ward AB, Wyatt RT, Li Y, Wilson IA, Zhu J, Shao Y.
    Immunity; 2016 Apr 19; 44(4):939-50. PubMed ID: 27067056
    [Abstract] [Full Text] [Related]

  • 14. Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.
    Ingale J, Tran K, Kong L, Dey B, McKee K, Schief W, Kwong PD, Mascola JR, Wyatt RT.
    J Virol; 2014 Dec 19; 88(24):14002-16. PubMed ID: 25253346
    [Abstract] [Full Text] [Related]

  • 15. Broadly neutralizing antibody epitopes on HIV-1 particles are exposed after virus interaction with host cells.
    Rao PG, Lambert GS, Upadhyay C.
    J Virol; 2023 Sep 28; 97(9):e0071023. PubMed ID: 37681958
    [Abstract] [Full Text] [Related]

  • 16. Rational Engraftment of Quaternary-Interactive Acidic Loops for Anti-HIV-1 Antibody Improvement.
    Liu Q, Zhang P, Miao H, Lin Y, Kwon YD, Kwong PD, Rikhtegaran-Tehrani Z, Seaman MS, DeVico AL, Sajadi MM, Lusso P.
    J Virol; 2021 May 24; 95(12):. PubMed ID: 33827946
    [Abstract] [Full Text] [Related]

  • 17. Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.
    LaBranche CC, Henderson R, Hsu A, Behrens S, Chen X, Zhou T, Wiehe K, Saunders KO, Alam SM, Bonsignori M, Borgnia MJ, Sattentau QJ, Eaton A, Greene K, Gao H, Liao HX, Williams WB, Peacock J, Tang H, Perez LG, Edwards RJ, Kepler TB, Korber BT, Kwong PD, Mascola JR, Acharya P, Haynes BF, Montefiori DC.
    PLoS Pathog; 2019 Sep 24; 15(9):e1008026. PubMed ID: 31527908
    [Abstract] [Full Text] [Related]

  • 18. Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.
    Townsley S, Li Y, Kozyrev Y, Cleveland B, Hu SL.
    J Virol; 2016 Jan 15; 90(2):829-41. PubMed ID: 26512079
    [Abstract] [Full Text] [Related]

  • 19. Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages.
    Behrens AJ, Kumar A, Medina-Ramirez M, Cupo A, Marshall K, Cruz Portillo VM, Harvey DJ, Ozorowski G, Zitzmann N, Wilson IA, Ward AB, Struwe WB, Moore JP, Sanders RW, Crispin M.
    J Proteome Res; 2018 Mar 02; 17(3):987-999. PubMed ID: 29420040
    [Abstract] [Full Text] [Related]

  • 20. Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies.
    McGuire AT, Hoot S, Dreyer AM, Lippy A, Stuart A, Cohen KW, Jardine J, Menis S, Scheid JF, West AP, Schief WR, Stamatatos L.
    J Exp Med; 2013 Apr 08; 210(4):655-63. PubMed ID: 23530120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.